MEIRAGTX HLDGS PLC's ticker is MGTX and the CUSIP is G59665102. A total of 85 filers reported holding MEIRAGTX HLDGS PLC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,646,421 | -26.9% | 538,986 | 0.0% | 0.28% | -25.4% |
Q2 2023 | $3,621,986 | +29.5% | 538,986 | 0.0% | 0.38% | +24.4% |
Q1 2023 | $2,797,337 | -22.7% | 538,986 | -2.9% | 0.31% | -18.8% |
Q4 2022 | $3,618,796 | -10.3% | 555,030 | 0.0% | 0.38% | -10.6% |
Q3 2022 | $4,035,000 | +6.6% | 555,030 | +11.0% | 0.42% | -1.6% |
Q2 2022 | $3,785,000 | -45.3% | 500,000 | 0.0% | 0.43% | -37.0% |
Q1 2022 | $6,925,000 | -33.8% | 500,000 | +11.1% | 0.68% | -1.7% |
Q4 2021 | $10,454,000 | +76.3% | 450,000 | 0.0% | 0.70% | +67.1% |
Q3 2021 | $5,931,000 | -15.0% | 450,000 | 0.0% | 0.42% | -12.1% |
Q2 2021 | $6,975,000 | +7.4% | 450,000 | 0.0% | 0.47% | +4.4% |
Q1 2021 | $6,494,000 | -4.7% | 450,000 | 0.0% | 0.45% | -18.5% |
Q4 2020 | $6,813,000 | +37.2% | 450,000 | +20.0% | 0.56% | +26.1% |
Q3 2020 | $4,965,000 | +32.2% | 375,000 | +25.0% | 0.44% | +8.6% |
Q2 2020 | $3,756,000 | +13.5% | 300,000 | +21.8% | 0.41% | -12.5% |
Q1 2020 | $3,310,000 | -13.6% | 246,307 | +28.8% | 0.46% | +10.5% |
Q4 2019 | $3,830,000 | – | 191,300 | – | 0.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Johnson & Johnson Innovation - JJDC, Inc. | 2,898,550 | $38,957,000 | 21.20% |
Prosight Management, LP | 568,348 | $7,639,000 | 3.57% |
Perceptive Advisors | 6,433,277 | $86,463,000 | 2.25% |
Orbimed Advisors | 3,582,320 | $48,146,000 | 0.81% |
Parkman Healthcare Partners LLC | 125,000 | $1,680,000 | 0.78% |
683 Capital Management, LLC | 831,748 | $11,178,000 | 0.66% |
Claraphi Advisory Network, LLC | 98,850 | $1,329,000 | 0.63% |
Fort Sheridan Advisors LLC | 54,512 | $733,000 | 0.54% |
Rhenman & Partners Asset Management AB | 246,307 | $3,310,000 | 0.46% |
PA Capital LLC | 39,039 | $525,000 | 0.46% |